• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析韩国新冠肺炎再次入院病例的危险因素:利用全国健康保险索赔数据。

Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.

机构信息

Department of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul 02447, Korea.

Department of Medical Education and Humanities, School of Medicine, Kyung Hee University, Seoul 02447, Korea.

出版信息

Int J Environ Res Public Health. 2020 Aug 12;17(16):5844. doi: 10.3390/ijerph17165844.

DOI:10.3390/ijerph17165844
PMID:32806775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7460295/
Abstract

In South Korea, 4.5% patients of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were readmitted to hospitals after discharge. However, there is insufficient research on risk factors for readmission and management of patients after discharge is poor. In this study, 7590 confirmed coronavirus disease (COVID-19) patients were defined as a target for analysis using nationwide medical claims data. The demographic characteristics, underlying diseases, and the use of medical resources were used to examine the association with readmission through the chi-square test and then logistic regression analysis was performed to analyze factors affecting readmission. Of the 7590 subjects analyzed, 328 patients were readmitted. The readmission rates of men, older age and patients with medical benefits showed a high risk of readmission. The Charlson Comorbidity Index score was also related to COVID-19 readmission. Concerning requiring medical attention, there was a higher risk of readmission for the patients with chest radiographs, computed tomography scans taken and lopinavir/ritonavir at the time of their first admission. Considering the risk factors presented in this study, classifying patients with a high risk of readmission and managing patients before and after discharge based on priority can make patient management and medical resource utilization more efficient. This study also indicates the importance of lifestyle management after discharge.

摘要

在韩国,有 4.5%的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 患者出院后会再次住院。然而,对于再次住院的风险因素的研究还不够充分,并且出院后的患者管理也很差。在这项研究中,使用全国性的医疗报销数据,将 7590 名确诊的新型冠状病毒病 (COVID-19) 患者定义为分析对象。通过卡方检验检查与再次住院相关的人口统计学特征、基础疾病和医疗资源使用情况,然后进行逻辑回归分析,以分析影响再次住院的因素。在分析的 7590 名患者中,有 328 名患者再次住院。男性、年龄较大和享受医疗福利的患者再次住院的风险较高。Charlson 合并症指数评分也与 COVID-19 再次住院有关。就需要医疗关注而言,在首次入院时进行胸部 X 光检查、计算机断层扫描检查和洛匹那韦/利托那韦的患者再次住院的风险更高。考虑到本研究中呈现的风险因素,可以根据优先级对有再次住院高风险的患者进行分类,并在出院前后进行管理,从而使患者管理和医疗资源利用更加高效。本研究还表明出院后生活方式管理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/756f/7460295/e691752685fb/ijerph-17-05844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/756f/7460295/e691752685fb/ijerph-17-05844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/756f/7460295/e691752685fb/ijerph-17-05844-g001.jpg

相似文献

1
Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.分析韩国新冠肺炎再次入院病例的危险因素:利用全国健康保险索赔数据。
Int J Environ Res Public Health. 2020 Aug 12;17(16):5844. doi: 10.3390/ijerph17165844.
2
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.2020 年韩国冠状病毒病疫情期间的接触者追踪。
Emerg Infect Dis. 2020 Oct;26(10):2465-2468. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16.
3
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.COVID-19 出院后返院患者的特征。
J Gen Intern Med. 2020 Oct;35(10):2838-2844. doi: 10.1007/s11606-020-06120-6. Epub 2020 Aug 19.
4
Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission - United States, March-August 2020.2020 年 3 月至 8 月美国出院后再次因 COVID-19 住院患者的特征
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1695-1699. doi: 10.15585/mmwr.mm6945e2.
5
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
6
Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study.韩国基础合并症对 COVID-19 感染和严重程度的影响:一项全国性病例对照研究。
J Korean Med Sci. 2020 Jun 29;35(25):e237. doi: 10.3346/jkms.2020.35.e237.
7
Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.基于西班牙急诊科收治的 1000 例患者系列,分析 COVID-19 患者的临床特征和结局。
Emergencias. 2020;32(4):233-241.
8
Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病的流行病学和临床特征。
Int J Infect Dis. 2020 Sep;98:462-466. doi: 10.1016/j.ijid.2020.07.017. Epub 2020 Jul 21.
9
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.韩国大邱市 98 例住院 SARS-CoV-2 感染患者的临床特征和结局:一项简要描述性研究。
Yonsei Med J. 2020 May;61(5):431-437. doi: 10.3349/ymj.2020.61.5.431.
10
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.伊朗 2019 冠状病毒病(COVID-19)患者的流行病学特征:一项单中心研究。
J Clin Virol. 2020 Jun;127:104378. doi: 10.1016/j.jcv.2020.104378. Epub 2020 Apr 21.

引用本文的文献

1
Risk factors for readmission of COVID-19 ICU survivors: A three-year follow up.新型冠状病毒肺炎重症监护病房幸存者再入院的危险因素:一项为期三年的随访研究
Indian J Med Res. 2025 Feb;161(2):190-198. doi: 10.25259/IJMR_726_2024.
2
COVID-19 Readmission Is Highest Among Refugees in Denmark.丹麦难民中新冠病毒病再入院率最高。
Int J Environ Res Public Health. 2025 Mar 3;22(3):367. doi: 10.3390/ijerph22030367.
3
Analysis of 30-day hospital readmissions and related risk factors for COVID-19 patients with myocarditis hospitalized in the United States during 2020.

本文引用的文献

1
Hospital Readmissions of Discharged Patients with COVID-19.新冠病毒感染出院患者的再次入院情况
Int J Gen Med. 2020 Dec 2;13:1359-1366. doi: 10.2147/IJGM.S275775. eCollection 2020.
2
Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China.新型冠状病毒2019(SARS-CoV-2)RNA阳性患者的临床病程及复发危险因素:一项来自中国武汉的回顾性队列研究
Aging (Albany NY). 2020 Sep 10;12(17):16675-16689. doi: 10.18632/aging.103795.
3
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.
2020年美国因心肌炎住院的COVID-19患者30天再入院情况及相关危险因素分析。
Proc (Bayl Univ Med Cent). 2024 Mar 19;38(1):34-41. doi: 10.1080/08998280.2024.2325280. eCollection 2025.
4
Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data.**药物处方模式及其与 COVID-19 患者死亡率和住院时间的关系:大数据洞察。**
Front Public Health. 2023 Dec 18;11:1280434. doi: 10.3389/fpubh.2023.1280434. eCollection 2023.
5
Characteristics of re-admitted adult patients infected with severe acute respiratory syndrome Coronavirus 2 After initial hospitalization at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.沙特阿拉伯塔布克的国王萨勒曼武装部队医院初次住院后再次入院的成人严重急性呼吸综合征冠状病毒 2 感染患者的特征。
Saudi Med J. 2023 Jul;44(7):647-654. doi: 10.15537/smj.2023.44.7.20220713.
6
The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course-A Narrative Review.糖尿病和高血糖对新型冠状病毒肺炎感染病程的影响——一篇叙述性综述
Front Clin Diabetes Healthc. 2022 Mar 10;3:812134. doi: 10.3389/fcdhc.2022.812134. eCollection 2022.
7
Readmission Risk after COVID-19 Hospitalization: A Moderation Analysis by Vital Signs.COVID-19 住院后再入院风险:生命体征的调节分析。
South Med J. 2022 Nov;115(11):842-848. doi: 10.14423/SMJ.0000000000001472.
8
Hospital readmissions and emergency department re-presentation of COVID-19 patients: a systematic review.新冠病毒肺炎患者的医院再入院及急诊科再次就诊情况:一项系统综述
Rev Panam Salud Publica. 2022 Oct 10;46:e142. doi: 10.26633/RPSP.2022.142. eCollection 2022.
9
Return visit characteristics of SARS-CoV-2 PCR-positive cases in a pediatric emergency department.儿科急诊中 SARS-CoV-2 PCR 阳性病例的复诊特征。
Turk J Med Sci. 2022 Feb;52(1):21-31. doi: 10.3906/sag-2102-281. Epub 2022 Feb 22.
10
Re-Admission of COVID-19 Patients Hospitalized with Omicron Variant-A Retrospective Cohort Study.奥密克戎变异株感染住院的COVID-19患者再次入院情况——一项回顾性队列研究
J Clin Med. 2022 Sep 2;11(17):5202. doi: 10.3390/jcm11175202.
COVID-19 出院后返院患者的特征。
J Gen Intern Med. 2020 Oct;35(10):2838-2844. doi: 10.1007/s11606-020-06120-6. Epub 2020 Aug 19.
4
Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam.康复患者新冠病毒检测呈阳性的可能原因和风险因素:文莱达鲁萨兰国的证据。
J Med Virol. 2020 Nov;92(11):2847-2851. doi: 10.1002/jmv.26199. Epub 2020 Jul 6.
5
Retest positive for SARS-CoV-2 RNA of "recovered" patients with COVID-19: Persistence, sampling issues, or re-infection?新冠肺炎“康复”患者的 SARS-CoV-2 RNA 复测阳性:持续性、采样问题还是再感染?
J Med Virol. 2020 Nov;92(11):2263-2265. doi: 10.1002/jmv.26114. Epub 2020 Jun 9.
6
Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study.出院的 2019 年冠状病毒病患者的临床特征和结局:一项前瞻性队列研究。
QJM. 2020 Sep 1;113(9):657-665. doi: 10.1093/qjmed/hcaa178.
7
Reactivation of COVID-19 pneumonia: A report of two cases.新型冠状病毒肺炎复阳:两例报告
J Infect. 2020 Aug;81(2):e72-e73. doi: 10.1016/j.jinf.2020.05.008. Epub 2020 May 7.
8
Risk of reactivation or reinfection of novel coronavirus (COVID-19).新型冠状病毒(COVID-19)再激活或再次感染的风险。
J Formos Med Assoc. 2020 Jun;119(6):1123. doi: 10.1016/j.jfma.2020.04.013. Epub 2020 Apr 23.
9
Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19).从新冠肺炎(COVID-19)中康复的年轻患者的直肠拭子呈阳性。
J Infect. 2020 Aug;81(2):e49-e52. doi: 10.1016/j.jinf.2020.04.023. Epub 2020 Apr 23.
10
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.